NCT04493255View on ClinicalTrials.gov

A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

October 21, 2020

Study Completion Date

October 21, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]E7090

\[14C\]E7090, oral capsule.

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit, Leeds

All Listed Sponsors
lead

Eisai Limited

INDUSTRY

NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants | Biotech Hunter | Biotech Hunter